Skip to main content
logo
Castle Biosciences, Inc. (CSTL)
NASDAQ: CSTL · Real-Time Price · USD
26.79
+2.33 (9.53%)
At close: Jul 30, 2026, 4:00 PM EDT
28.75
+1.96 (7.32%)
After-hours: Jul 30, 2026, 5:07 PM EDT

Castle Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Cap
8131,1557595926251,088
Market Cap Growth
72.34%52.13%28.33%-5.37%-42.55%-34.70%
Enterprise Value
587.58892.21492.29363.76379.76766.42
Last Close Price
26.7938.9026.6521.5823.5442.87
PE Ratio
--42.98---
PS Ratio
2.393.352.292.694.5611.56
PB Ratio
1.612.451.671.511.572.64
P/TBV Ratio
2.123.042.232.112.253.34
P/FCF Ratio
179.8440.7720.77---
P/OCF Ratio
16.8417.9511.70---
EV/Sales Ratio
1.732.591.481.662.778.15
EV/EBITDA Ratio
--19.96---
EV/EBIT Ratio
--56.78---
EV/FCF Ratio
130.0531.5013.47---
Debt / Equity Ratio
0.070.070.050.040.030.02
Debt / EBITDA Ratio
--1.07---
Debt / FCF Ratio
-1.300.72---
Net Debt / Equity Ratio
-0.49-0.56-0.58-0.58-0.61-0.78
Net Debt / EBITDA Ratio
13.94128.79-10.824.093.948.77
Net Debt / FCF Ratio
470.67-9.27-7.3011.835.1914.31
Asset Turnover
0.630.620.670.490.300.21
Inventory Turnover
7.807.737.497.5510.677.47
Quick Ratio
5.584.996.975.907.8113.94
Current Ratio
6.045.267.296.208.0914.21
Return on Equity (ROE)
-4.17%-5.24%4.31%-14.54%-16.56%-11.78%
Return on Assets (ROA)
-5.70%-6.32%1.49%-15.12%-15.60%-10.82%
Return on Invested Capital (ROIC)
-13.63%-17.66%4.16%-42.92%-58.18%-98.53%
Return on Capital Employed (ROCE)
-6.33%-8.63%1.95%-16.64%-17.16%-9.36%
Earnings Yield
--2.33%---
FCF Yield
0.56%2.45%4.81%---
Buyback Yield / Dilution
-4.45%0.92%-9.15%-2.87%-3.65%-32.80%
Total Shareholder Return
-4.45%0.92%-9.15%-2.87%-3.65%-32.80%
SEC Filings: 10-K · 10-Q